期刊文献+

慢性肾脏病患者钙磷代谢紊乱及其治疗策略 被引量:11

Calcium/phosphate metabolism disorder of chronic kidney disease patients and its treatment strategies
原文传递
导出
摘要 钙磷代谢紊乱是慢性肾脏病(CKD)特别是透析患者常见的并发症之一,可导致各类肾性骨病,还可促进血管钙化,增加心血管事件的死亡风险,有效控制和管理钙磷代谢紊乱与CKD患者的长期预后密切相关。本文总结CKD患者钙磷代谢紊乱的发病情况、危害、监测频率、靶目标值及其治疗策略,从维持正常血钙、降低高血磷、控制异常甲状旁腺激素水平等方面简要综述钙磷代谢的管理策略。 Calcium/phosphate metabolism disorder is a common complication of chronic kidney disease(CKD), especially for dialysis patients. It could cause various bone diseases and increase the risk of vascular calcification and cardiovascular events. Therefore, it is very important to control and manage calcium/phosphate metabolism disorder effectively. This paper describes the pathogenesis and clinical harm of calcium/phosphate metabolism disorder on CKD patients, and summarizes the control target and treatment strategies, including maintaining normal serum calcium, reducing elevated phosphate levels and controlling abnormal PTH levels.
作者 李婉莎 余毅 LI Wan-sha, YU Yi(Department of Blood Purification, Fuzhou General Hospital of PLA, Fuzhou 350025, Chin)
出处 《世界临床药物》 CAS 2018年第3期204-210,共7页 World Clinical Drug
基金 福建省科技计划重点项目(编号:2013Y0069)
关键词 慢性肾脏病(CKD) 钙磷代谢 监测频率 临床治疗 管理策略 chronic kidney disease (CKD) calcium/phosphate metabolism frequency of measurement treatment management strategy
  • 相关文献

参考文献5

二级参考文献90

  • 1刘书馨,常明,刘红,王志宏,刘焱,藤兰波,赵华.血管平滑肌细胞凋亡与尿毒症血管钙化[J].中华肾脏病杂志,2007,23(6):362-365. 被引量:3
  • 2Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol, 2009,29 : 761-766.
  • 3Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle ceils. Atherosclerosis, 2008,199 : 271 - 277.
  • 4Mizobuehi M, Ogata H, Hatamura I, et al. Up-regulation of Cbfal and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. Nephrol Dial Transplant, 2006 ,21:911-916.
  • 5Ballanti P, Silvestrini G, Pisano S, et al. Medial artery calcification of uremic patients: a histological, histochemical and ultrastructural study. Histol Histopatho1,2011,26 : 191-200.
  • 6Lau WL, Pal A, Moe SM, et al. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis, 2011,18 : 105- 112.
  • 7Zavaczki E, Jeney V, Agarwal A, et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle ceils. Kidney Int,2011,80:731-739.
  • 8Du Y, Wang Y, Wang L, et al. Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2. Circ Res, 2011,108: 917- 928.
  • 9Chen NX, Moe SM. Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep, 2012, 14 : 228 - 237.
  • 10Foley RN, Collins AJ, Herzog CA, et al. Serum phosphorus levels associate with coronary atherosclerosis in young a- dults. J Am Soc Nephrol, 2009,20 : 397 -404.

共引文献70

同被引文献134

引证文献11

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部